Established in 2005, Jilin Qijian Bio-Pharmaceutical Co., Ltd. is a cGMP approved pharmaceutical company in China. We specialized in the R&D, production and sales of APIs and FDFs to global customers. Our hGH API got certificate of EU-WC, also filed in US-FDA DMF.
The factory covers an area of 30,000 square meters, with 16,000 square meters of production workshops including standard genetic engineering production lines, biochemical synthesis production lines, chemical synthesis production lines, sterilized freeze-dried system and small volume injection production lines complying with the GMP regulations. Over 20 years of development, Qijian professionals are constantly committed to developing, manufacturing and commercializing innovative chemical & biological pharmaceuticals covering many therapeutic areas, including cerebrovascular nerve repair, endocrinology, anti-aging and liver disease, etc.
Qijian adheres to the concept of "responsibility, innovation, and integrity", focuses on human health and well-being, changes the future through technology, and achieves beyond user expectations.
The main products are gene recombinant protein(Somatropin), butyphalide,Monosialotetrahexosylganglioside Sodium (GM1) and Ademetionine 1,4-Butanedisulfonate (SAM), cliclitiede etc.
Year of Establishment:
2005
Total Assets(USD):
choose not to disclose
Total Number of Staff:
200 to 249
Main Competitive Advantages:
Other Competitive Advantages:
Qijian has the first-class research talents, including research and development personnel more than 40 people, production staff hundreds of people. R&D Dept. is a young energetic, creative and motivated team, it is highly accomplished in gene engineering, pharmacology, chemistry and microbiology, it has a wealth of experience in new product research, development and production.
Patents and Copyrights:
Business Type:
Manufacturer,Trading Company
R&D capacity:
Annual Turnover(USD):
choose not to disclose
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Other Competitive Advantages:
Qijian has the first-class research talents, including research and development personnel more than 40 people, production staff hundreds of people. R&D Dept. is a young energetic, creative and motivated team, it is highly accomplished in gene engineering, pharmacology, chemistry and microbiology, it has a wealth of experience in new product research, development and production.
Patents and Copyrights:
Five years of qualification
Audited Supplier
Pharma Sources Insight June 2024: Globalization on the Go
